BioCentury | Sep 18, 2020
Emerging Company Profile

Synthekine launches with $82M to create new cytokine signals

...Nils Lonberg as an independent member of its board; Lonberg was formerly scientific director at GenPhar Inc....
BioCentury | Sep 26, 2011
Company News

GenPhar infectious, cancer news

...Dong was arrested and subsequently released on $50,000 bond. Dong, who is now CSO of GenPhar...
...indictments note that Dong made the illegal contributions without being detected by Graham's campaign staff. GenPhar...
...required by federal law, any fraudulent contributions will be handed over to the U.S. Treasury. GenPhar Inc....
BioCentury | Jan 15, 2007
Clinical News

GenPhar, ImmuneRegen, Virion preclinical data

...animals. Viprovex is derived from modified substance P, a naturally occurring immunomodulator and homeostatic compound. GenPhar Inc....
BioCentury | Oct 14, 2002
Clinical News

GenPhar preclinical data

...a CRADA between GenPhar and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). GenPhar Inc....
BioCentury | Oct 7, 2002
Company News

GenPhar other research news

...fully protected from Marburg virus infection, while control guinea pigs died within days from infection. GenPhar Inc....
BioCentury | Apr 1, 2002
Company News

GenPhar other research news

...USAMRIID) entered into a CRADA to test a multivalent vaccine for Marburg virus in animals. GenPhar Inc....
Items per page:
1 - 6 of 6
BioCentury | Sep 18, 2020
Emerging Company Profile

Synthekine launches with $82M to create new cytokine signals

...Nils Lonberg as an independent member of its board; Lonberg was formerly scientific director at GenPhar Inc....
BioCentury | Sep 26, 2011
Company News

GenPhar infectious, cancer news

...Dong was arrested and subsequently released on $50,000 bond. Dong, who is now CSO of GenPhar...
...indictments note that Dong made the illegal contributions without being detected by Graham's campaign staff. GenPhar...
...required by federal law, any fraudulent contributions will be handed over to the U.S. Treasury. GenPhar Inc....
BioCentury | Jan 15, 2007
Clinical News

GenPhar, ImmuneRegen, Virion preclinical data

...animals. Viprovex is derived from modified substance P, a naturally occurring immunomodulator and homeostatic compound. GenPhar Inc....
BioCentury | Oct 14, 2002
Clinical News

GenPhar preclinical data

...a CRADA between GenPhar and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). GenPhar Inc....
BioCentury | Oct 7, 2002
Company News

GenPhar other research news

...fully protected from Marburg virus infection, while control guinea pigs died within days from infection. GenPhar Inc....
BioCentury | Apr 1, 2002
Company News

GenPhar other research news

...USAMRIID) entered into a CRADA to test a multivalent vaccine for Marburg virus in animals. GenPhar Inc....
Items per page:
1 - 6 of 6